Research
Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care
Jennifer G McIntosh, Jesse Minshall, Sibel Saya, Adrian Bickerstaffe, Nadira Hewabandu, Ashleigh Qama and Jon D Emery
British Journal of General Practice 2019; 69 (689): e836-e842. DOI: https://doi.org/10.3399/bjgp19X706841
Jennifer G McIntosh
Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia.
BAppSci, MPH, PhDRoles: Senior research fellow
Jesse Minshall
Western Health, Melbourne, Australia.
BSc, MDRoles: Medical resident
Sibel Saya
Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia.
BSc, MGCRoles: PhD candidate
Adrian Bickerstaffe
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Australia.
BCompSci(Hons), PhDRoles: Head of research computing
Nadira Hewabandu
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Australia.
BSc(Hons)Roles: Senior informatics officer
Ashleigh Qama
WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, Melbourne, Australia.
BSc(Hons)Roles: Epidemiologist
Jon D Emery
Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia; Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, UK.
MA, MRCGP, FRACGP, DPhilRoles: Herman professor of primary care cancer research
Jump to comment:
No eLetters have been published for this article.
In this issue
British Journal of General Practice
Vol. 69, Issue 689
December 2019
Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care
Jennifer G McIntosh, Jesse Minshall, Sibel Saya, Adrian Bickerstaffe, Nadira Hewabandu, Ashleigh Qama, Jon D Emery
British Journal of General Practice 2019; 69 (689): e836-e842. DOI: 10.3399/bjgp19X706841
Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care
Jennifer G McIntosh, Jesse Minshall, Sibel Saya, Adrian Bickerstaffe, Nadira Hewabandu, Ashleigh Qama, Jon D Emery
British Journal of General Practice 2019; 69 (689): e836-e842. DOI: 10.3399/bjgp19X706841
Jump to section
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals